# Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-everolimus-in-patients-with-locally-advanced-or-metastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Emmanuel Seront,Sylvie Rottey,Brieuc Sautois,Joseph Kerger,Lionel D’Hondt,Vincent Verschaeve,Jean Luc Canon,Catherine Dopchie,Jean‐Marie Vandenbulcke,Nicolas Whenham,Jean‐Charles Goeminne,Marylène Clausse,Didier Verhoeven,Philippe Glorieux,Samuel Branders,Pierre Dupont,Joelle M. Schoonjans,Olivier Féron,J.-P. Machiels |
| Citations | 125 |
| DOI | 10.1093/annonc/mds057 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.annalsofoncology.org/article/S0923753419379499/pdf |
| OpenAlex ID | https://openalex.org/W2102804476 |
| PMID | 22473592 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Vincent Verschaeve](https://scholariq.org/researchers/vincent-verschaeve/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.